We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.16%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$776M
AUM Growth
-$138M
Cap. Flow
-$176M
Cap. Flow %
-22.7%
Top 10 Hldgs %
36.6%
Holding
70
New
9
Increased
23
Reduced
28
Closed
8

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$25.7M
2
DXCM icon
DexCom
DXCM
+$24.4M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$20M
4
VTRS icon
Viatris
VTRS
+$19.2M
5
NUVA
NuVasive, Inc.
NUVA
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 92.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REGN icon
26
Regeneron Pharmaceuticals
REGN
$70.5B
$14.7M 1.9%
32,917
-29,981
-48% -$14.3M
EW icon
27
Edwards Lifesciences
EW
$48.9B
$14.5M 1.87%
397,740
-83,400
-17% -$3.18M
NBIX icon
28
Neurocrine Biosciences
NBIX
$17.4B
$14.3M 1.84%
232,602
-6,105
-3% -$322K
PRTA icon
29
Prothena Corp
PRTA
$454M
$12.7M 1.63%
195,909
+44,863
+30% +$2.75M
EVH icon
30
Evolent Health
EVH
$667M
$11.6M 1.5%
652,680
+119,868
+22% +$2.47M
ONCE
31
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$10.4M 1.34%
116,599
+15,299
+15% +$1.16M
WMGI
32
DELISTED
Wright Medical Group Inc
WMGI
$9.67M 1.25%
373,672
+50
+0% +$1.38K
IRTC icon
33
iRhythm Holdings
IRTC
$3.66B
$9.61M 1.24%
185,200
+30
+0% +$1.36K
CI icon
34
Cigna
CI
$75.1B
$8.53M 1.1%
45,615
+30,105
+194% +$5.36M
NUVA
35
DELISTED
NuVasive, Inc.
NUVA
$7.34M 0.95%
132,290
-260,999
-66% -$17.3M
ZLAB icon
36
Zai Lab
ZLAB
$2.32B
$7.17M 0.92%
+265,600
New +$7.41M
IART icon
37
Integra LifeSciences
IART
$1.47B
$7.11M 0.92%
140,778
-103,220
-42% -$5.3M
MNTA
38
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6.89M 0.89%
372,499
+73,099
+24% +$1.22M
MASI
39
DELISTED
Masimo
MASI
$6.3M 0.81%
72,800
-500
-0.7% -$44.2K
NDRM
40
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$5.75M 0.74%
147,756
-202,329
-58% -$7.44M
EXAS
41
DELISTED
Exact Sciences
EXAS
$5.54M 0.71%
+117,550
New +$4.73M
VRTX icon
42
Vertex Pharmaceuticals
VRTX
$122B
$5.17M 0.67%
+34,000
New +$5.12M
EVHC
43
DELISTED
Envision Healthcare Holdings Inc
EVHC
$5.11M 0.66%
113,600
-19,620
-15% -$1.05M
RARX
44
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.06M 0.52%
278,082
+99,332
+56% +$1.5M
INCY icon
45
Incyte
INCY
$23.1B
$3.94M 0.51%
33,745
+11,900
+54% +$1.51M
PTCT icon
46
PTC Therapeutics
PTCT
$6.47B
$3.41M 0.44%
170,535
+109,800
+181% +$2.15M
ALBO
47
DELISTED
Albireo Pharma Inc
ALBO
$3.31M 0.43%
158,027
-30,685
-16% -$732K
AGIO icon
48
Agios Pharmaceuticals
AGIO
$2.38B
$3.19M 0.41%
47,799
-75,800
-61% -$4.55M
INDP icon
49
Indaptus Therapeutics
INDP
$328M
$3.18M 0.41%
+158
New +$2.28M
SRPT icon
50
Sarepta Therapeutics
SRPT
$1.78B
$3.13M 0.4%
69,099
+40,300
+140% +$1.61M

Similar funds

Sectoral Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Sectoral Asset Management held 70 positions worth $776M, down 15% from $914M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management withdrew a net $176M in Q3 2017, closing 8 positions and reducing 28 holdings. Its most notable exit was DexCom, an estimated $24.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 94% a quarter earlier.

Against the trend, Sectoral Asset Management opened a new position in UnitedHealth worth $19.2M.

  • Sectoral Asset Management's largest Q3 2017 buy was UnitedHealth: 98,205 shares worth $19.2M.
  • Sectoral Asset Management added most to Clovis Oncology, Inc. in Q3 2017, an estimated $17.4M increase.
  • Sectoral Asset Management's biggest Q3 2017 reduction was Merck, cutting an estimated $25.7M.
  • Sectoral Asset Management fully exited DexCom in Q3 2017, selling an estimated $24.4M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $776M portfolio in Q3 2017.
  • Sectoral Asset Management opened 9 new positions and closed 8 in Q3 2017.
  • Sectoral Asset Management's portfolio value fell 15% quarter-over-quarter to $776M.

Based on Sectoral Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.